A breakthrough medical innovation that began life at Stevenage Bioscience Catalyst has become the first non-hormonal menopause treatment in its class to be approved by the UK’s Medicines and ...

AbCellera Biologics (ABCL) marks a milestone, transitioning to clinical-stage biotech with ABCL635 dosing and pipeline expansion.

Bayer AG (BAYRY) reported second-quarter 2025 core earnings of 35 cents per American Depositary Receipt (ADR), which ...